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he small GTPase Rho acts on two effectors, ROCK and
mDia1, and induces stress ﬁbers and focal adhesions.
However, how ROCK and mDia1 individually regulate
signals and dynamics of these structures remains unknown.
We stimulated serum-starved Swiss 3T3 ﬁbroblasts with LPA
and compared the effects of C3 exoenzyme, a Rho inhibitor,
 
with those of Y-27632, a ROCK inhibitor. Y-27632 treat-
ment suppressed LPA-induced formation of stress ﬁbers
and focal adhesions as did C3 exoenzyme but induced
membrane rufﬂes and focal complexes, which were absent
in the C3 exoenzyme-treated cells. This phenotype was
suppressed by expression of N17Rac. Consistently, the
amount of GTP-Rac increased signiﬁcantly by Y-27632 in
T
 
LPA-stimulated cells. Biochemically, Y-27632 suppressed
tyrosine phosphorylation of paxillin and focal adhesion
kinase and not that of Cas. Inhibition of Cas phosphorylation
with PP1 or expression of a dominant negative Cas mutant
inhibited Y-27632–induced membrane rufﬂe formation.
Moreover, Crk-II mutants lacking in binding to either
phosphorylated Cas or DOCK180 suppressed the Y-27632–
induced membrane rufﬂe formation. Finally, expression of
a dominant negative mDia1 mutant also inhibited the
membrane rufﬂe formation by Y-27632. Thus, these results
have revealed the Rho-dependent Rac activation signaling
that is mediated by mDia1 through Cas phosphorylation
and antagonized by the action of ROCK.
 
Introduction
 
Cells adopt different shapes in response to different stimuli.
For example, interphase nonmotile Swiss 3T3 fibroblasts
extend filopodia or lamellipodia or form stress fibers and focal
adhesions in response to bradykinin, PDGF, and lysophos-
phatidic acid (LPA),* respectively, and these changes are
mediated respectively by the Rho family small GTPases,
Cdc42, Rac, and Rho (Hall, 1998). Migrating fibroblasts
also exhibit lamellipodia, filopodia, and actin bundles with
focal adhesions. However, in these cells those structures are
observed in different places of a single cell. Filopodia and
lamellipodia are seen in the leading edge of the cell, actin
bundles similar to stress fibers are running from the front to
the rear, and focal adhesions are at the tips of these bundles
(Mitchison and Cramer, 1996; Horwitz and Parsons, 1999).
It is also noteworthy that these structures change in space as
the cell migrates. There is accumulating evidence that the
Rho family small GTPases participate also in these shape
changes of migrating cells (Allen et al., 1998; Nobes and
Hall, 1999). However, how the activities of these GTPases
are regulated spatiotemporally in migrating cells remains
largely unknown.
The actions of the Rho GTPases are mediated by the re-
spective groups of downstream effectors (Schmitz et al.,
2000). Using the selective binding to the GTP-bound active
form of Rho, several effectors of Rho were isolated (Narumiya,
1996). Among them, the ROCK–ROK–Rho kinase family
of serine-threoine protein kinases has been found essential in
Rho-induced formation of stress fibers and focal adhesions.
Expression of a dominant negative form of this kinase or the
addition of a specific inhibitor of this kinase Y-27632 inhibits
stress fibers and focal adhesions induced by LPA or activated
Rho in several cell lines (Ishizaki et al., 1997; Uehata et al.,
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1997). However, expression of a dominant active ROCK mu-
tant alone leads to the formation of an aberrant form of cen-
trally contracted actin bundles in the cell (Leung et al., 1996;
Amano et al., 1997; Ishizaki et al., 1997), indicating that
other Rho effector(s) cooperate to induce well-aligned stress
fibers. We found recently that coexpression of an active mu-
tant of another Rho effector, mDia1, corrected the alignment
of actin bundles induced by active ROCK (Watanabe et al.,
1999). Our subsequent study indicates that this mDia1 action
is exerted through its action on microtubule (MT) alignment
(Ishizaki et al., 2001). The structures of the actin cytoskeleton
induced by ROCK and mDia1 reflect the pattern and loca-
tion of focal adhesions induced by each of them. Dominant
active ROCK mutants induce abnormally large adhesions not
only in the cell periphery but also in the center of the cells. On
the other hand, expression of active mDia1 mutants induces
small adhesions at the tips of the cell. Theses results suggest
that ROCK and mDia differently regulate shapes and loca-
tions of focal adhesions. However, how these two molecules
affect signals and dynamics of focal adhesions remains un-
known. There are several studies suggesting the regulation, by
multiple Rho effector(s), of the processes involving the cell to
substrate adhesion. For example, Nobes and Hall (1999) ex-
amined effects of C3 exoenzyme and Y-27632 on REF cells
subjected to the in vitro wound healing assay and found that
the C3 exoenzyme treatment abolished the cell migration,
whereas Y-27632 stimulated it. Y-27632 was also reported
not to block the G1 to S phase progression of the cell cycle in
Swiss 3T3 cells (Ishizaki et al., 2000), which is sensitive to the
C3 exoenzyme treatment (Yamamoto et al., 1993).
In this study, we compared the effects of C3 exoenzyme
with those of Y-27632 first morphologically on rearrange-
ment of actin cytoskeleton and focal adhesion and then bio-
chemically on tyrosine phosphorylation of focal adhesion
proteins. We also tested the effects of overexpression of sev-
eral signaling molecules and inhibitors of Src and MT dy-
namics on the elicitation of the phenotype induced by
ROCK inhibition. Our findings show that there is a dichot-
omy of the signaling from Rho, one being mediated by
ROCK leading to tyrosine phosphorylation of focal adhe-
sion kinase (FAK) and paxillin and the other mediated by
mDia1 resulting in phosphorylation of Cas, and that the lat-
ter mDia1 pathway leads to activation of Rac, which is an-
tagonistically regulated by the former ROCK pathway.
 
Results
 
Different effects of C3 exoenzyme and Y-27632 on 
LPA-induced actin reorganization and formation of 
focal adhesions in Swiss 3T3 cells
 
We stimulated serum-starved Swiss 3T3 fibroblasts with LPA
and examined the effects of C3 exoenzyme that shuts off all
of the Rho signals and those of Y-27632 that selectively in-
hibit ROCK-mediated pathway downstream of Rho. We
first assessed their effects on actin cytoskeleton and focal ad-
hesions by staining cells with phalloidin and antiphosphoty-
rosine antibody, respectively (Fig. 1 A). As originally shown
by Ridley and Hall (1992), LPA addition to serum-starved
3T3 cells spread the cells and induced stress fibers and focal
 
adhesions in a few minutes, and this change was completely
inhibited by prior C3 exoenzyme treatment. The C3 exoen-
zyme-treated cells remained round with many beaded pro-
cesses. On the other hand, the addition of Y-27632 did not
affect the morphology of serum-starved cells, and when LPA
was added to these cells they flattened and spread as seen in
control cells. However, they did not develop actin stress fi-
bers, but a thick rim of F-actin accumulation was seen in the
cell periphery. Simultaneous staining with antiphosphoty-
rosine showed numerous small dot-like structures beneath
this F-actin accumulation, which resembled Rac-induced fo-
cal complexes. Video microscopy revealed that LPA addition
evoked robust membrane ruffles in the periphery of the
Y-27632–treated cells (Fig. 1 B), suggesting that the thick ac-
tin rim detected by phalloidin staining represents membrane
ruffles. We examined the specificity of this Y-27632 effect by
two additional experiments. First, the addition of Y-27632 to
the C3 exoenzyme-treated cells did not evoke LPA-induced
cell spreading and membrane ruffles (Fig. S1 available at
http://www.jcb.org/cgi/content/full/jcb.200112107/DC1).
Second, the addition of PDGF could induce membrane ruf-
fles in the C3 exoenzyme-treated cells (Fig. S2 available at
http://www.jcb.org/cgi/content/full/jcb.200112107/DC1).
These results indicate that the membrane ruffles seen in the
Y-27632–treated cells occur in a Rho-dependent, ROCK-
independent manner.
 
Rac is activated by a Rho-dependent,
ROCK-independent signaling
 
Because membrane ruffles are usually induced by Rac activa-
tion, we suspected that Rac is activated under the above condi-
tions and induces membrane ruffles in the Y-27632–treated
cells. Therefore, we transfected Swiss 3T3 cells with dominant
negative Rac (N17Rac) and examined the effect of its expres-
sion on the LPA-induced membrane ruffling in Y-27632–
treated cells. As shown in Fig. 2 A, the cells expressing N17Rac
showed no rim-like accumulation of F-actin in the periphery,
and F-actin dispersed in the cytoplasm. Thin F-actin spikes
were also seen around the cell periphery. These cells did not
show dot-like accumulation of antiphosphotyrosine staining in
the cell periphery either, and anti-phosphotyrosine staining ac-
cumulated in the cytoplasm as seen in C3 exoenzyme-treated
cells. This phenotype was observed in 200 cells in a total of
235 cells observed in three independent experiments. These
results suggest that activation of Rac occurred in the Y-27632–
treated cells upon LPA addition and was responsible for mem-
brane ruffle formation. To confirm this hypothesis biochem-
ically, we performed the pull-down assay for GTP-Rac using
a glutathione 
 
S
 
-transferase (GST) fusion of the CRIB domain
of Pak (Sander et al., 1998). As shown in Fig. 2 B, virtually no
GTP-Rac was pulled down from lysates of any groups of se-
rum-starved cells tested. A small but significant amount of
GTP-Rac was precipitated from the lysates of the control cells
stimulated with LPA. The precipitation of GTP-Rac was sig-
nificantly enhanced in the Y-27632–treated cells stimulated
with LPA and not in the C3 exoenzyme-treated cells. These re-
sults verified that Rac was activated in the Y-27632–treated
cells upon LPA addition and suggest that this activation is in-
duced by the Rho-dependent, ROCK-independent signaling. 
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Tyrosine phosphorylation of p130Cas occurs through 
the Rho-dependent, ROCK-independent signaling
 
To elucidate the above Rho-dependent, ROCK-indepen-
dent signaling biochemically, we compared the effects of C3
exoenzyme and Y-27632 on LPA-induced tyrosine phos-
phorylation of focal adhesion proteins. Swiss 3T3 cells were
treated with either vehicle, C3 exoenzyme, or Y-27632 for
the indicated times and then stimulated with LPA for 0, 5,
and 30 min. Cell lysates were prepared and subjected to im-
munoblotting and immunoprecipitation analysis. As shown
in Fig. 3 A, LPA addition induced tyrosine phosphorylation
of proteins of 
 
 
 
70 and 120–130 kD, which correspond to a
group of phosphorylated paxillin isoforms and a combined
band of p125FAK and p130Cas, respectively. The C3 ex-
oenzyme treatment suppressed tyrosine phosphorylation of
both groups of proteins as reported previously (Kumagai et
Figure 1. Effects of C3 exoenzyme and Y-27632 on 
actin reorganization and localization of tyrosine-
phosphorylated proteins in LPA-stimulated Swiss 
3T3 cells. (A) Immunofluorescence. Swiss 3T3 cells 
were maintained in DME containing 10% FBS for 3 d 
and cultured in serum-free DME for 24 h. During this 
period, the cells were without any treatment or 
treated with either 30  g/ml C3 exoenzyme for 4 d 
or with 30  M Y-27632 for 30 min and then exposed 
to 5  M LPA for 0 and 5 min. The cells were fixed, 
permeabilized, and stained with Texas red phalloidin 
for F-actin (red) and antiphosphotyrosine antibody 
(green). The top panels show the merged images of 
the cells without LPA stimulation. The F-actin stain-
ing, the phosphotyrosine staining, and the merged 
images of the LPA-stimulated cells are shown in the 
second, third, and the bottom rows of the panels, 
respectively. Note that the cells treated with Y-27632 
display a thick rim of F-actin and dot-like phospho-
tyrosine staining in the cell periphery upon the addition 
of LPA. (B) Video microscopy. Swiss 3T3 cells trans-
fected with GFP actin were serum starved for 24 h 
and treated with 30  M Y-27632 for the last 30 min. 
LPA was added at 5  M, and the cell shape change 
was monitored in the continued presence of Y-27632 
by time-lapse confocal microscopy as the image of 
GFP actin. The number in each image indicates time 
after the LPA addition in min. See also the video 
available at http://www.jcb.org/cgi/content/full/
jcb.200112107/DC1. Bars, 20  m. 
822 The Journal of Cell Biology 
 
|
 
 
 
Volume 157, Number 5, 2002
 
al., 1993; Rankin et al., 1994; Needham and Rozengurt,
1998). On the other hand, Y-27632 suppressed tyrosine
phosphorylation of the 70-kD group but only partially af-
fected that of the 120–130-kD group. The tyrosine phos-
phorylation of the latter group declined at 30 min in the
control cells, whereas it remained high in the Y-27632–
treated cells. Immunoprecipitation experiments using anti-
paxillin, anti-FAK, and anti-Cas antibodies revealed that
Y-27632 treatment suppressed tyrosine phosphorylation of
paxillin and FAK to the extent similar to that achieved by
C3 exoenzyme treatment, whereas it barely inhibited the
phosphorylation of Cas (Fig. 3 B). The same result was ob-
tained by immunoblotting with antipaxillin, anti-FAK, and
anti-Cas antibodies of proteins precipitated with antiphos-
photyrosine monoclonal antibody (Fig. 3 C). These results
suggest the presence of a dichotomy of the signaling from
Rho to the tyrosine phosphorylation of focal adhesion pro-
Figure 2. LPA-induced Rac activation in Y-27632–treated Swiss 
3T3 cells. (A) Inhibition of membrane ruffles by expression of 
N17Rac in Y-27632–treated cells. Swiss 3T3 cells were transfected 
with 1  g of pCMV5–N17Rac or 1  g of pEGFP–C1. The trans-
fected cells were cultured in DME containing 10% FBS for 16 h and 
then in serum-free DME for 24 h. The cells were treated with 30  M 
Y-27632 for 30 min and then stimulated with LPA for 5 min. The 
cells were stained for F-actin and phosphotyrosine as described in 
the legend to Fig. 1. Arrows indicate transfected cells identified with 
anti-GFP (top) or anti-Flag staining (bottom). Note that membrane 
ruffles and focal complexes disappeared in the cells overexpressing 
N17Rac. Bar, 20  m. (B) Pull-down assay for GTP-Rac. Swiss 3T3 
cells were cultured and treated with either C3 exoenzyme or 
Y-27632 as described in the legend to Fig. 1. The cells were then 
stimulated with 5  M LPA for 0 and 5 min and subjected to the 
pull-down assay as described in Materials and methods. GTP-Rac 
precipitated from each cell lysates was analyzed by immunoblotting 
with anti-Rac antibody (top), and the total amounts of Rac present in 
the cell lysates are shown in the immunoblot in the bottom panels. 
 , cells without any pretreatment; Y, cells treated with Y-27632; 
C3, cells treated with C3 exoenzyme. Note that GTP-Rac increased 
in amount significantly by Y-27632 treatment and remained little in 
the C3 exoenzyme-treated cells.
Figure 3. Different effects of C3 exoenzyme and Y-27632 on 
tyrosine phosphorylation of focal adhesion proteins. (A) Effects of C3 
exoenzyme and Y-27632 on LPA-induced tyrosine phosphorylation. 
Swiss 3T3 cells were cultured and treated either with none, C3 
exoenzyme, or Y-27632 as described in the legend to Fig. 1. The cells 
were then stimulated with 5  M LPA for 0, 5, and 30 min. The cell 
lysates were prepared and subjected to SDS-PAGE and immuno-
blotting using antiphosphotyrosine antibody. A single asterisk and 
double asterisk indicate the tyrosine-phosphorylated paxillin isoforms 
and the combined band of phosphorylated FAK and Cas, respectively. 
(B and C) Inhibition of tyrosine phosphorylation of FAK and paxillin 
but not that of Cas by Y-27632 treatment. The lysates of cells stimu-
lated with LPA for 5 min were subjected to immunoprecipitation 
using either antipaxillin, anti-FAK, or anti-p130Cas antibodies (B) or 
using antiphosphotyrosine antibody (C). The immunoprecipitates 
were then analyzed by immunoblotting with antiphosphotyrosine 
antibody (B) or with antipaxillin, anti-FAK, and anti-p130Cas antibod-
ies (C).  , cells without any pretreatment; Y, cells treated with 
Y-27632; C3, cells treated with C3 exoenzyme. Note that Y-27632 
treatment suppressed tyrosine phosphorylation of paxillin and FAK 
but not that of Cas, whereas the phosphorylation of these three 
proteins were equally suppressed by C3 exoenzyme treatment. 
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teins; one is mediated by ROCK and induces the phosphor-
ylation of paxillin and FAK, and the other is ROCK inde-
pendent and leads to the phosphorylation of Cas.
 
Tyrosine phosphorylation of Cas is required for 
LPA-induced membrane ruffling in Y-27632–treated cells
 
As previously reported (Sakai et al., 1994; Klinghoffer et
al., 1999), p130Cas was tyrosine phosphorylated by the
Src family of kinases. Therefore, we examined LPA-induced
changes in Y-27632–treated cells in the presence of PP1, a
specific inhibitor of Src family kinases (Hanke et al.,
1996). Consistent with the previous report (Okuda et
al., 1999), the treatment with PP1 significantly decreased
the level of tyrosine phosphorylation of Cas (Fig. 4 A). Un-
der these conditions, LPA-induced morphological changes
were also inhibited (Fig. 4 B). The peripheral accumula-
tion of F-actin was greatly suppressed, and F-actin was seen
as disorganized tangles in the cytoplasm. Focal complexes
beneath the membrane ruffles disappeared. These changes
were observed in almost all PP1-treated cells. We also used
the pull-down assay and have found that the level of GTP-
Rac was significantly suppressed by the PP1 treatment
(Fig. 4 C). These results suggest that the Cas phosphoryla-
tion leads to Rac activation and evokes membrane ruffles.
To confirm this, we transfected 3T3 cells with Cas
 
 
 
SD.
Cas
 
 
 
SD is a Cas mutant with a deletion of the tyrosine
phosphorylation sites by Src kinase (Nakamoto et al.,
1997), and overexpression of this mutant works as a domi-
nant negative form in Cas signaling involving the phos-
phorylation (Klemke et al., 1998). As shown in Fig. 4 D,
no LPA-induced membrane ruffling was seen, and the dot-
like focal complexes disappeared in the Y-27632–treated
cells expressing Cas
 
 
 
SD. F-actin was dispersed in the cyto-
plasm as observed in the cells expressing RacN17 (Fig. 2
A). This phenotype was observed in 48 cells out of 50 Cas
 
 
 
 
SD-expressing cells in three independent experiments.
 
Overexpression of CrkII(R38K) and CrkII(W170K) 
inhibits LPA-induced membrane ruffling in 
Y-27632–treated cells
 
Tyrosine phosphorylation of Cas provides a binding site
for Crk, which then binds DOCK180 to make a Cas–
Crk–DOCK180 complex (O’Neill et al., 2000). Because
DOCK180 is known as an activator for Rac (Kiyokawa et
al., 1998), we examined the involvement of this complex
formation in LPA-induced ruffling in our system. To this
Figure 4. Inhibition of LPA-induced membrane ruffles by 
inhibiting tyrosine phosphorylation of Cas in Y-27632–treated cells. 
(A and B) Effects of PP1 on tyrosine phosphorylation of Cas and 
membrane ruffles induced by LPA. Swiss 3T3 cells were cultured 
and serum starved as described in the legend to Fig. 1. The serum-
starved cells were treated with either DMSO (control) or 50  M PP1 
(PP1) in the presence of 30  M Y-27632 for 30 min and then 
stimulated with LPA for 5 min. The cells were then lysed for 
immunoprecipitation and immunoblotting analysis for tyrosine 
phosphorylation of Cas (A). Alternatively, the cells were fixed 
and stained for F-actin and phosphotyrosine as described above (B). 
Note that the PP1 treatment significantly inhibited Cas phosphorylation 
as shown by the immunoblot analysis and reduced the number of dot-like structures of tyrosine-phosphorylated proteins as illustrated by 
antiphosphotyrosine staining. Significant suppression of membrane ruffles is also noted in the PP1-treated cells. (C) Effects of PP1 on the level 
of GTP-Rac in Y-27632–treated cells. The cells were cultured and treated as described above and then subjected to the pull-down assay 
for GTP-Rac. Control, cells treated with Y-27632 alone; PP1, cells treated with both Y-27632 and PP1. (D) Inhibition of LPA-induced 
membrane ruffles by expression of Cas SD, a tyrosine phosphorylation-defective Cas mutant, in Y-27632–treated cells. Swiss 3T3 cells were 
transfected with 1  g of pSSR –Cas SD and cultured as described in the legend to Fig. 2 A. The cells were then treated with 30  M Y-27632 
for 30 min and stimulated with 5  M LPA for 5 min in the continued presence of Y-27632. The cells were fixed, and F-actin and tyrosine-
phosphorylated proteins were stained as described above. The cells expressing Cas SD were identified by HA tag staining and are indicated 
by arrows. Bars, 20  m. 
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purpose, we used two CrkII mutants. One is CrkII(R38K)
that has a mutation in its SH2 region and is devoid of bind-
ing to Cas, and the other is CrkII(W170K) that has a muta-
tion in its NH
 
2
 
-terminal SH3 region and is devoid of bind-
ing to DOCK180 (Albert et al., 2000). Overexpression of
either of the two mutants significantly blunted the LPA-
induced responses in Y-27632–treated cells. The cells express-
ing the CrkII mutants did not spread and did not develop
membrane ruffling (Fig. 5 A). The dot-like staining with an-
tiphosphotyrosine antibody was not seen either in the cell
periphery. Suppression of the membrane ruffles was found
in all of the 20 CrkII(R38K) cells and 23 out of 24
CrkII(W170K) cells observed in three independent experi-
ments. Together, these results suggest that Rac activation
through Rho-dependent, ROCK-independent pathway in
LPA-stimulated cells is mediated through Cas phosphoryla-
tion and the induction of the Cas–Crk–DOCK180 com-
plex. Consistently, the Cas–Crk complex was formed in
LPA-stimulated cells, and this formation was inhibited by
treatment with either C3 exoenzyme or PP1 (Fig. 5 B).
 
Effects of mDia1 mutants on LPA-induced membrane 
ruffling in Y-27632–treated cells
 
The next question is the identity of the Rho effector mediating
the Rho signaling to Cas phosphorylation. An obvious candi-
date is mDia1 because mDia1 cooperates with ROCK to in-
duce stress fibers and focal adhesions (Watanabe et al., 1999).
The interaction of mDia with Src was also reported (Tomi-
naga et al., 2000). To identify the involvement of mDia1, we
first prepared several truncation constructs of mDia1
 
 
 
N3.
mDia1
 
 
 
N3 is a dominant active mutant that induces thin
stress fibers and small focal adhesions in HeLa cells (Watanabe
et al., 1999; Ishizaki et al., 2001). Mutants interfering with
this phenotype are, therefore, expected to work as dominant
negative forms in cells in physiological situations. Because
mDia1
 
 
 
N3 consists of several domains and deletion of any of
these domains leads to the loss of the active phenotype, we sus-
pected that truncation mutants of this active mutant might
compete with the full mDia1
 
 
 
N3 and interfere with its ac-
tion. To test this possibility, we made mutants H 
 
  
 
P, F2,
CC, and mDia1
 
 
 
N3(HindIII) (Fig. 6 A). Among these mu-
Figure 5. Cas–Crk interaction in LPA-induced 
membrane ruffles in Y-27632–treated cells. 
(A) Inhibition of the ruffle formation by expression 
of CrkII mutants. The cells were transfected 
either with 1  g of pEEB–CrkII(R38K) and 0.1 
 g of pEGFP–C1 (top) or with 1  g of pEEB–
CrkII(W170K) and 0.1  g of pEGFP–C1 
(bottom) and cultured as described in the 
legend to Fig. 2 A. The cells were then treated 
with 30  M Y-27632 for 30 min and stimulated 
with 5  M LPA for 5 min in the continued 
presence of Y-27632. The cells were fixed, and 
F-actin and tyrosine-phosphorylated proteins 
were stained as described above. The cells 
expressing each CrkII mutant were identified 
with anti-GFP staining and are indicated by 
arrows. Arrowheads indicate nontransfected 
cells. Note that the cell bodies of the cells 
expressing these CrkII mutants retracted, and 
the dot-like structure of tyrosine-phosphorylated 
proteins disappeared in the cell periphery. 
Bar, 20  m. (B) Rho-dependent formation of 
the Cas–Crk complex in LPA-stimulated cells. 
Swiss 3T3 cells were cultured and treated with 
indicated reagents as described in the legends 
for Figs. 1 and 4. After stimulated with LPA for 
0 and 5 min, the cells were lysed and subjected 
to immunoprecipitation with anti-Crk mAb. 
The immunoprecipitates were then analyzed by 
Western blot analysis with anti-Cas antibody. 
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Figure 6. Effects of various mDia1 fragments on the mDia1 N3 
phenotype in HeLa cells. (A) Schematic diagram of the structures of 
mDia1 and truncation mutants. The domain structure of mDia1 is shown 
above. The Rho-binding domain and the FH1 and FH2 regions are shown 
by hatched boxes. The FH3 region that partially overlaps with the Rho-
binding domain and the two coiled-coil regions are indicated by a thick 
line and two-headed arrows, respectively. Truncation mutants,  N3, 
H   P, F2.  N3(HindIII) and CC are shown by the lines below. Numbers 
indicate the amino acid number at the NH2 and COOH terminals of each 
protein and domain. (B and C) Effects of various fragments on the mDia1 N3 
phenotype. HeLa cells were transfected with 0.2  g of pFL–mDia1 N3 
either alone or with 2  g of pEGFP plasmid encoding either mDia1 
H   P, F2,  N3(HindIII), or CC mutant. After the culture for 24 h, the 
cells were fixed and stained for F-actin (top) and  -tubulin (bottom) (B). 
Arrows indicate the cells expressing each construct. The ratios of the long 
versus short axis were measured in the cells expressing each construct and 
are shown (C). Note that expression of either H   P, F2, or  N3(HindIII) 
inhibits the cell elongation and the parallel alignment of F-actin bundles 
and MTs induced by mDia1 N3. 
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tants, H 
 
  
 
P, F2, and mDia1
 
 
 
N3(HindIII) potently inhib-
ited cell elongation and interfered with alignment of actin fi-
bers and MTs induced by mDia1
 
 
 
N3 (Fig. 6, B and C). We
then expressed these three mDia1 mutants individually in
Swiss 3T3 cells and examined LPA-induced cell morphology
in Y-27632–treated cells. Expression of mDia1
 
 
 
N3(HindIII)
(Fig. 7) significantly inhibited LPA-induced membrane ruf-
fling in Y-27632–treated cells. The dot-like focal complexes
disappeared, and spreading was inhibited as seen in the cells
expressing the Crk dominant negative mutants. This suppres-
sion was observed in 28 out of 30 cells expressing this con-
struct. In contrast, the mDia1
 
 
 
N3(HindIII) expression did
not inhibit the spreading and ruffle formation induced by
PDGF. On the other hand, expression of either of the other
two shorter mutants did not inhibit the LPA-induced mem-
brane ruffle formation (unpublished data), suggesting that in-
terference with endogenous mDia1 requires simultaneous
blocking of various mDia1 domains. These results indicate
that mDia1 works specifically as a switch of Rho activation to
Rac activation.
 
Effects of MT disruption on Y-27632–induced 
membrane ruffling in serum-stimulated cells
 
Then, how does mDia1 mediate this action? We demonstrated
that active mDia1 induces MT orientation to align actin fibers
(Ishizaki et al., 2001). Kaverina et al. (1999) also suggested that
MTs can promote cell protrusion by targeting focal adhesions
and exerting relaxing effects. Therefore, we examined the effects
of MT disruption by nocodazole on Y-27632–induced mem-
brane ruffling. Because nocodazole treatment caused detach-
ment of serum-starved cells from the dish, we added Y-27632
to cells cultured with serum and examined the effect of nocoda-
zole. The addition of Y-27632 induced membrane ruffling also
in serum-cultured cells, whereas the addition of nocodazole
alone induced strong stress fibers as reported previously (Eno-
moto, 1996) (Fig. 8). On the other hand, combined addition of
Y-27632 and nocodazole greatly attenuated stress fibers, indi-
cating that Y-27632 sufficiently inhibited the ROCK activity
also in these cells. Notably, this combined treatment also sup-
pressed membrane ruffle formation, suggesting that membrane
ruffle formation induced by Y-27632 depends on the activity of
intact MTs. To test if disruption of microtubules could affect
tyrosine phosphorylation of Cas, we analyzed tyrosine phos-
phorylation of Cas in control cells and cells treated with
Y-27632 alone, nocodazole alone, or nocodazole and Y-27632.
However, the Cas phosphorylation in these serum-maintained
cells was low compared with the LPA-stimulated cells, and we
could not detect any change in Cas phosphorylation among the
groups of cells tested (unpublished data).
 
Discussion
 
ROCK and mDia1 antagonize in Rho-dependent 
Rac activation
 
In this study, by comparing the effects of C3 exoenzyme and
Y-27632 on LPA-induced morphological change in serum-
Figure 7. Inhibition of LPA-induced membrane ruffles by expression of mDia1 N3(HindIII) in Y-27632–treated cells. Swiss 3T3 cells 
were transfected with 1  g of pEGFP plasmid encoding  N3(HindIII) and cultured as described in the legend to Fig. 2 A. The cells were 
treated with 30  M Y-27632 for 30 min and then stimulated with 5  M LPA for 5 min in the continued presence of Y-27632. Alternatively, 
the cells were stimulated with 5 ng/ml PDGF for 10 min without Y-27632 or LPA treatment. The cells were fixed, and F-actin and tyrosine-
phosphorylated proteins were stained as described above. Left and middle panels show the cells stimulated with Y-27632 and LPA. The 
right panel shows cells stimulated with PDGF. Arrows indicate the cells expressing GFP– N3–HindIII as identified by anti-GFP antibody 
staining. Arrowheads indicate nontransfected cells. Note that LPA-induced membrane ruffle formation is significantly suppressed by 
expression of mDia1– N3(HindIII). Bar, 20  m. 
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starved Swiss 3T3 fibroblasts, we have first found that Rac is
activated in a Rho-dependent manner, and this activation oc-
curs when the ROCK pathway downstream of Rho is se-
lectively inhibited. Induction of membrane ruffles by the
Y-27632 treatment was reported previously by Rottner et al.
(1999). These authors attributed this effect of ROCK inhibi-
tion to the presumed antagonism of Rho on Rac pathway
originally observed in neuronal cells (Kozma et al., 1997; Van
Leeuwen et al., 1997; Hirose et al., 1998). However, our find-
ings that membrane ruffle formation and Rac activation were
only seen in Y-27632–treated cells and not in cells treated
with C3 exoenzyme argue against this hypothesis and suggest
that a pathway mediated by other Rho effector(s) is responsi-
ble for this induction. Our subsequent analysis has indeed re-
vealed that this Rac activation was evoked by the Rho-depen-
dent tyrosine phosphorylation of Cas and the consequent
formation of the Cas–Crk–DOCK180 complex. We have
further found that the Y-27632–induced membrane ruffle
formation was potently inhibited by expression of the domi-
nant negative form of mDia1. mDia1 cooperates with ROCK
downstream of Rho for correct induction of focal adhesions
and stress fibers through MT alignment (Watanabe et al.,
1999; Ishizaki et al., 2001). Binding of mDia1 to Src kinase
and involvement of Src kinase in some mDia1-mediated ac-
tions was also reported (Tominaga et al., 2000). Src family ki-
nases are also known to be responsible for integrin-dependent
Cas phosphorylation (Klinghoffer et al., 1999). Consistently,
the Y-27632–induced membrane ruffles in Swiss 3T3 cells
were suppressed by disruption of MTs by nocodazole and in-
hibition of Src kinase by PP1. Together, these results suggest
that mDia1 is an effector molecule mediating the Rho signal
to Rac activation, and the ROCK pathway antagonizes this
pathway of Rho-dependent Rac activation.
Then, how does the ROCK pathway antagonize the
mDia1-mediated Rac activation? Because the level of GTP-
Rac increases with ROCK inhibition (Fig. 2 B), the site of
inhibition should be localized within the pathway from
mDia1 to Rac activation by DOCK180. This inhibition site
probably lies downstream of Cas because tyrosine phosphor-
ylation of Cas was not enhanced by ROCK inhibition (Fig.
3, B and C). ROCK may interfere with this pathway
through phosphorylation of paxillin. Yano et al. (2000) re-
ported that paxillin 
 
  and Cas exert opposing effects on cell
migration in a manner dependent on tyrosine phosphoryla-
tion of each protein. In this study, we have shown that ty-
rosine phosphorylation of paxillin is mediated by the ROCK
pathway (Fig. 3, B and C).
Tyrosine phosphorylation of focal adhesion proteins oc-
curs in many types of cells under a variety of stimuli, which
utilize different signaling pathways. Therefore, our present
findings naturally cannot be applied to every cell type. For
example, in vascular endothelial cells stimulated with sphin-
gosine-1 phosphate, tyrosine phosphorylation of Cas occurs
in a manner not dependent on Rho (Ohmori et al., 2001),
whereas similar to our finding bombesin induces Cas phos-
phorylation in a Rho-dependent, Y-27632–insensitive man-
ner in Swiss 3T3 cells (Sinnett-Smith et al., 2001).
Implication of the dichotomy of the Rho signaling in 
the cell to substrate adhesion
The above findings suggest that two Rho effectors act differ-
ently downstream of Rho in the regulation of cell to sub-
Figure 8. Effects of nocodazole on Y-27632–induced membrane ruffles. Swiss 3T3 cells were cultured in DME containing 10% FBS and 
treated with or without 30  M Y-27632 in the presence or absence of 100 ng/ml nocodazole for 30 min. The cells were fixed and then 
stained for F-actin (top) and  -tubulin (bottom). Note that treatment of Y-27632 induced membrane ruffles at the tips of cells and that the 
addition of nocodazole inhibited the Y-27632–induced membrane ruffles. Bar, 20  m.828 The Journal of Cell Biology | Volume 157, Number 5, 2002
strate adhesion and actin reorganization. Then, what is the
implication of this dichotomy of the Rho signaling? The sig-
naling and cytoskeletal dynamics that occur in cell spreading
and adhesion as we analyzed in this study are generally
thought to mimic events in migrating cells. Indeed, the bi-
modal Rho actions in migrating cells were suggested by an in
vitro wound healing experiment using REF cells. Nobes and
Hall (1999) microinjected two doses of C3 exoenzyme into
migrating REF cells and found that the low dose that was
sufficient to abolish stress fibers and focal adhesions did not
affect cell migration, whereas the high dose completely in-
hibited cell migration. They also found that Y-27632 treat-
ment accelerated the migration of the cells. The latter find-
ing appears to be consistent with our current findings that
treatment with Y-27632 and not C3 exoenzyme induces
membrane ruffles. We have also found that treatment with
Y-27632 and not C3 exoenzyme enhances the LPA-induced
migration of Swiss 3T3 cells in the transwell assay (unpub-
lished data). These results together with the above findings
with the different doses of C3 exoenzyme suggest that the
ROCK and mDia pathways differ in their sensitivities to C3
exoenzyme, the former being preferentially affected by the
low dose and the latter becoming affected by the high dose.
Such different sensitivities to C3 exoenzyme may indicate
that activation of these two Rho pathways depend on the
level of GTP-Rho in the cell, the low level being sufficient
for the mDia1 pathway and the high level being required for
the ROCK pathway. The level of GTP-Rho in the cell is
regulated by both guanine nucleotide exchange factor and
GTPase-activating protein (GAP) selective to this GTP-
ase. Recently, Arthur and Burridge (2001) reported that
the overexpression of wild-type p190RhoGAP facilitates
spreading and migration of fibroblasts, whereas that of
dominant negative p190RhoGAP (RA) inhibits these pro-
cesses and that these phenotypes correlated with the low
and high GTP-Rho levels, respectively. The phenotype in-
duced by wild-type p190RhoGAP are similar to those of
Y-27632–treated cells we described here, suggesting that
p190RhoGAP may decrease the GTP-Rho level to inter-
fere with the ROCK pathway. Consistently, they reported
that the phenotype induced by the dominant negative
p190RhoGAP (RA) mutant was reversed by the low dose of
C3 exoenzyme. These results are consistent with a widely
held view that the basal Rho activity is essential for cell mi-
gration and spreading (Nobes and Hall, 1999; Arthur and
Burridge, 2001). Interestingly, the activity of p190RhoGAP
is regulated through phosphorylation by c-Src that is acti-
vated in an integrin-dependent manner (Arthur et al.,
2000). mDia1 may mediate this recruitment of Src to focal
adhesions.
The dichotomy of the Rho signaling in the cell to sub-
strate adhesion may also be important in the regulation of
the cell cycle by Rho. The G1 to S phase progression of
Swiss 3T3 cells is inhibited by C3 exoenzyme but not by
Y-27632 (Yamamoto et al., 1993; Ishizaki et al., 2000). It is
interesting to examine whether the mDia1-mediated signal-
ing we described here works in this process. Another process
where the mDia1-mediated signaling may work is Ras-
induced cell transformation. Although Rho signaling is essen-
tial in Ras-induced transformation (Qiu et al., 1995), nei-
ther stress fibers nor focal adhesions are found in Ras-trans-
formed cells, indicating that the Rho signaling is somehow
modified in these cells. Sahai et al. (2001) reported that
ROCK is down-regulated by both decreased expression and
the cytoskeletal sequestration, whereas the level of GTP-Rho
is elevated in Ras-transformed cells. These results indicate
that the Rho signaling other than the ROCK pathway is im-
portant in the Ras-induced malignant transformation.
Rho-dependent Rac activation and the spatiotemporal 
control of cell migration
Cell migration is presumably performed by concerted for-
mation of filopodia, lamellipodia, and actomyosin contrac-
tion each induced by the Rho family GTPases, Cdc42, Rac,
and Rho (Mitchison and Cramer, 1996). Previously, the hi-
erarchical activation of Cdc42 to Rac and then to Rho was
shown and suggested to work in a cascade in cell migration
(Chant and Stowers, 1995). However, these studies did not
provide any information on activation of Rac or Cdc42 by
Rho, which is essential to resume the migration cycle. Our
present findings have for the first time demonstrated that
the Rho signaling has a built-in switch for Rac activation.
We have found that this switch is mediated by mDia1 and
inhibited by ROCK. In this respect, it is interesting that
mDia1 recruits MT ends to focal adhesions (Ishizaki et al.,
2001) and that targeting of focal adhesions by MTs appears
to inhibit the ROCK activity there (Kaverina et al., 1999).
Together, these results suggest that the Rho-dependent Rac
activation may be switched on in a positive feedback manner
by mDia1. In migrating cells, signaling pathways of these
Rho GTPases are regulated not only temporally but also spa-
tially. mDia1 was previously shown to be localized in mem-
brane ruffles of motile cells (Watanabe et al., 1997). On the
other hand, recent studies suggest that the ROCK activity is
required in the tail retraction of migrating monocytes and
neutrophils (Worthylake et al., 2001). Thus, the two Rho
signaling pathways may operate differently in space in mi-
grating cells, the mDia1 and ROCK pathways preferentially
in the front and the rear, respectively.
Materials and methods
Materials
LPA, nocodazole, anti-FLAG monoclonal antibody (M2), and anti– -tubu-
lin antibody (TUB.2.1) were purchased from Sigma-Aldrich. Antiphospho-
tyrosine polyclonal antibody (PY20) and monoclonal antibody (4G10)
were purchased from Zymed Laboratories and Upstate Biotechnology, re-
spectively. Clone 2A7 and clone 77 anti-FAK monoclonal antibodies were
purchased from Upstate Biotechnology and Transduction Laboratory, re-
spectively. Antipaxillin monoclonal antibody was purchased from Zymed
Laboratories. PDGF-BB, anti-Rac1, and anti-Crk antibodies were pur-
chased from Upstate Biotechnology. Anti-p130Cas polyclonal antibody
was reported previously (Nakamoto et al., 1997). Y-27632, a ROCK inhib-
itor, was supplied by Mitsubishi Pharma. Botulinum C3 exoenzyme was
purified as described (Morii and Narumiya, 1995). GST-PAK CRIB protein
was prepared as described previously (Matsuo et al., 2002).
Plasmids
pE–green fluorescent protein (GFP)–C1 was purchased from CLONTECH
Laboratories, Inc. pSSR –p130Cas SD, pEEB–CrkII(R38K), and pEEB–
CrkII(W170K) were described previously (Nakamoto et al., 1997; Albert et
al., 2000). pFL–mDia1 N3, pEGFP–mDia1–F2, and pEGFP–mDia1–H   P
were constructed as described previously (Watanabe et al., 1999; Ishizaki et
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pFL–mDia1–Full (Watanabe et al., 1999) as a template using a forward
primer (5 -TTCCTCGAGGCCTTCGGCCTCGCCTC-3 ) and a reverse
primer (5 -TTCGGATCCGTCCATCACACCTGTCTCATC-3 ). The product
was digested with XhoI and BamHI and inserted into a XhoI-BamHI frag-
ment of pEGFP–C1. For construction of pEGFP–mDia1 N3(HindIII), pGEX–
4T–mDia1 N3 was digested with BglII and HindIII. The insert was ligated
with a BglII-HindIII fragment of pEGFP–C1. pCMV5–FLAG–N19Rac was
described previously (Hirose et al., 1998). pEGFP actin was constructed as
follows. Mouse  -actin cDNA was amplified from adult mouse brain
mRNA using reverse transcriptase–PCR. NcoI-FSPI fragment was inserted
between Asp718I and BamHI sites in pEGFP–C1 with the blunt-end liga-
tion. The resultant plasmid contains mouse  -actin ORF fused to the
COOH terminus of EGFP in frame with the linker of 17 amino acids.
Cell culture and transfection
For LPA stimulation of nontransfected cells, Swiss 3T3 cells were plated at
densities of 2   10
4 and 2   10
5 cells per 35- and 60-mm dish for immu-
nofluorescence study or immunoprecipitation assay, respectively, and cul-
tured in DME containing 10% FCS for 3 d. The cells were washed twice
with Ca
2 - and Mg
2 -free PBS( ) and cultured in serum-free DME for 24 h.
During this period, the cells were without treatment or treated either with
30  g/ml C3 exoenzyme all through the culture of 4 d or with 30  M
Y-27632 for the last 30 min. The cells were then stimulated with 5  M LPA for
the indicated times in the continued presence of C3 coenzyme or Y-27632.
The cells were either fixed or lysed as described below. For transfection,
Swiss 3T3 cells were plated on a cover glass at a density of 2   10
4 cells per
22-mm dish and cultured in DME containing 10% FCS for 24 h. The cells
were washed with PBS( ) once and incubated with the indicated amounts
of plasmid DNA(s) mixed with 1  l of Lipofectamine 2000 for 3 h in 1 ml of
OPTI-MEM (GIBCO BRL). The medium was replaced with DME containing
10% FCS, and the cells were cultured for 18 h. The cells were then cultured
in serum-free DME for 24 h and treated with Y-27632 for the last 30 min.
The cells were stimulated with 5  M LPA for the indicated times in the con-
tinued presence of Y-27632. The cells were fixed and stained as described
below. As indicated, PDGF stimulation on nontransfected or transfected
cells was performed at 5 ng/ml concentration for 10 min.
HeLa cells were plated on a cover glass at a density of 5   10
4 cells per
35-mm dish and cultured in DME containing 10% FCS for 24 h. The cells
were washed once and incubated with 0.2  g of pFL–mDia1 N3 with or
without 2  g of the pEGFP plasmid encoding each mDia1 mutant mixed
with 4  l of Lipofectamine (GIBCO BRL) for 3 h in 1 ml of OPTI-MEM
(GIBCO BRL). The medium was replaced with DME containing 10% FCS,
and the cells were cultured for 18 h. The cells were then fixed and stained.
Immunofluorescence study
The cells were washed once with PBS( ) and fixed as follows. HeLa cells
were fixed with 4% formaldehyde as described previously (Ishizaki et al.,
2001). Swiss 3T3 cells were fixed first for 1 min with 4% formaldehyde and
0.1% Triton X-100 in PBS and then for 15 min with 4% formaldehyde alone
in PBS. Both lines of the cells were permeabilized by washing in PBS( )
containing 0.1% Triton X-100 for 5 min and incubated with PBS( ) contain-
ing 3% BSA for 1 h at room temperature. Primary antibodies were diluted in
PBS( ) containing 1% BSA and included the antibodies against pTyr (1:100),
 -tubulin (1: 200), the Flag tag (1:100), and the GFP tag (1:100). F-actin was
always stained with Texas red phalloidin (Molecular Probes). In double
staining for F-actin and phosphotyrosine, Alexa Fluor 488–conjugated goat
anti–mouse IgG (H   L) (Molecular Probes) was used as the secondary anti-
body. In triple staining for F-actin, phosphotyrosine, and tag epitopes, Alexa
Fluor 488–conjugated goat anti–mouse IgG (H   L) was used for detection
of the signal of the tag epitope, and Alexa Fluor 633–conjugated goat anti–
rabbit IgG (H   L) (Molecular Probes) was used for detection of the signal of
rabbit polyclonal antibody to phosphotyrosine. Alexa Fluor 594–conjugated
goat anti–rabbit IgG (H   L) (Molecular Probes) was used as the secondary
antibody for detection of MTs. Optical sections of 0.3- m thickness were
obtained from the bottom with a Bio-Rad Laboratories MRC1024 Confocal
Imaging System, and built-up images were constructed.
Videomicroscopy
Swiss 3T3 cells were seeded at a density of 2   10
4 per dish in a 35-mm
glass-bottom dish (Matsunami Glass) and cultured for 24 h. The cells were
transfected with 1  g of pEGFP actin as described above and then main-
tained for 3 d. The cells were starved in serum-free DME for 24 h and
treated with 30  M Y-27632 for the last 30 min. The dish was transferred to
a temperature-controlled ZEISS CO2 incubator attached to the microscope
stage. 5  M LPA was then added, and the cell movement was monitored at
37 C in 5% CO2 for 90 min using a ZEISS confocal laser scanning unit (LSM
510-V2.5). Three successive optical sections of 0.6- m thickness were ob-
tained from the bottom every 90 s, and built-up images were constructed.
Western blot analysis and immunoprecipitation
Swiss 3T3 cells were washed once with ice-cold PBS( ) and lysed on ice
for 5 min with modified RIPA buffer containing 50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1% NP-40, 0.25% SDS, 0.25% sodium deoxycholate, 1
mM sodium fluoride, 1 mM sodium orthovanadate, 1  g/ml leupeptin, 1
 g/ml aprotinin, 1  g/ml pepstatin, 1 mM EGTA, and 1 mM PMSF. The
samples were centrifuged at 12,000 g for 20 min, and the supernatant was
collected as the cell lysates. Protein concentration of the lysates was deter-
mined by the Lowry method. For Western blot analysis using the total cell
lysates, one fifth volume of the 5  Laemmli sample buffer was added to
the lysates. The mixtures were boiled for 5 min and subjected to SDS-
PAGE and Western blot analysis using antiphosphotyrosine antibody
(4G10) as described (Needham and Rozengurt, 1998). For immunoprecip-
itation, 50  g of each cell lysate was incubated with 1  g of either anti-
p130Cas polyclonal antibody, anti-FAK monoclonal antibody, antipaxil-
lin monoclonal antibody, or antiphosphotyrosine monoclonal antibody
(4G10). 30  l of either protein A–Sepharose (for precipitation of anti-
p130Cas antibody complex only) or protein G–Sepharose (Amasham Phar-
macia Biotech) were then added, and incubation was performed for 3 h at
4 C. The Sepharose beads were washed three times with the lysis buffer
and suspended with an equal volume of 2  Laemmli sample buffer. The
suspensions were boiled, and the extracts were subjected to Western blot
analysis using the indicated antibodies. Immunoprecipitation of Crk was
performed as described (Gu et al., 2001).
Pull-down assay
Swiss 3T3 cells were plated at a density of 5   10
5 cells per 10-cm dish.
Culture, treatment with Y-27632, or C3 exoenzyme and LPA stimulation
were performed as described above. The cells were washed once with ice-
cold PBS( ) and lysed in the pull-down lysis buffer containing 50 mM Tris-
HCl, pH 7.5, 100 mM NaCl, 2 mM MgCl2, 10% glycerol, 1% NP-40, 1  g/
ml leupeptin, 1  g/ml aprotinin, 1  g/ml pepstatin, 1 mM sodium fluoride,
1 mM EGTA, and 1 mM PMSF. The samples were centrifuged at 12,000 g
for 20 min, and the supernatants were saved as the cell lysates. After protein
concentration was determined by the Lowry method, 200  g protein of cell
lysate was incubated with 20  g protein of GST-PAK CRIB immobilized on
glutathione–Sepharose 4B beads (Amersham Pharmacia Biotech) for 1 h at
4 C. Beads were washed three times with the pull-down buffer, and bound
GTP-Rac1 was detected by Western blot with anti-Rac1 antibody.
Online supplemental materials
Fig. S1, showing the effect of Y-27632 on morphology of C3 exoenzyme-
treated cells, Fig. S2, showing the effect of PDGF on morphology of C3
exoenzyme-treated cells, and the video, showing LPA-induced mem-
brane ruffling of Y-27632–treated cells, are available online at http://
www.jcb.org/cgi/content/full/jcb.200112107/DC1.
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